Back to search

Article

Metabolic Biomarkers for Peripheral Artery Disease Compared with Coronary Artery Disease: Lipoprotein and metabolite profiling of 31,657 individuals from five prospective cohorts

2020-07-25

Abstract excerpt

<h4>Background</h4> Peripheral artery disease (PAD) and coronary artery disease (CAD) represent atherosclerosis in different vascular beds. We conducted detailed metabolic profiling to identify biomarkers for the risk of developing PAD and compared with risk of CAD to explore common and unique risk factors for these different vascular diseases. <h4>Methods</h4> We measured blood biomarkers using nuclear magnetic r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0de59d5f-fe1e-5c34-a04c-e125ab355085
DOI
10.1101/2020.07.24.20158675
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metabolic Biomarkers for Peripheral Artery Disease Compared with Coronary Artery Disease: Lipoprotein and metabolite profiling of 31,657 individuals from five prospective cohortsDOI 10.1101/2020.07.24.20158675
Causal evidence for an ApoB-independent metabolomic risk profile associated with coronary artery diseaseSemantic proximity
Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risksSemantic proximity
A combined observational and Mendelian randomization investigation reveals NMR-measured analytes to be risk factors of major cardiovascular diseasesSemantic proximity
Coronary artery disease, genetic risk and the metabolome in young individualsSemantic proximity
Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes.Semantic proximity
Genomics of lipid metabolism : identification of genetic determinants of lipid metabolites and the effect of perturbations of lipid levels on coronary heart disease risk factorsSemantic proximity
Beyond Cholesterol: A Comprehensive Review and Disease Architecture Reassessment of Lipid and Lipoprotein Biomarkers in ASCVDSemantic proximity
Cardiometabolic Risks: Cellular and Molecular MechanismsSemantic proximity
Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA.Semantic proximity
Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia.Semantic proximity
Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery DiseaseSemantic proximity
Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease.Semantic proximity
Select a neighboring publication to make it the new centre.